A detailed history of Simplex Trading, LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 15,980 shares of SNDX stock, worth $209,018. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,980
Previous 5,873 172.09%
Holding current value
$209,018
Previous $120,000 155.83%
% of portfolio
0.01%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$17.93 - $24.81 $181,218 - $250,754
10,107 Added 172.09%
15,980 $307,000
Q2 2024

Jul 25, 2024

SELL
$18.82 - $23.79 $108,327 - $136,935
-5,756 Reduced 49.5%
5,873 $120,000
Q1 2024

Apr 25, 2024

SELL
$19.71 - $24.57 $1.03 Million - $1.29 Million
-52,401 Reduced 81.84%
11,629 $276,000
Q4 2023

Feb 02, 2024

BUY
$11.39 - $21.67 $729,301 - $1.39 Million
64,030 New
64,030 $1.38 Million
Q4 2022

Feb 02, 2023

BUY
$20.64 - $26.24 $4,375 - $5,562
212 New
212 $5,000
Q2 2022

Aug 03, 2022

SELL
$13.64 - $19.48 $12,971 - $18,525
-951 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$14.84 - $22.15 $22,022 - $32,870
-1,484 Reduced 60.94%
951 $16,000
Q4 2021

Feb 23, 2022

BUY
$15.23 - $22.47 $37,085 - $54,714
2,435 New
2,435 $53,000
Q1 2021

Apr 26, 2021

SELL
$19.28 - $24.59 $26,066 - $33,245
-1,352 Closed
0 $0
Q4 2020

Feb 02, 2021

BUY
$15.1 - $26.44 $20,415 - $35,746
1,352 New
1,352 $30,000
Q3 2020

Oct 14, 2020

SELL
$13.39 - $17.48 $624,817 - $815,669
-46,663 Closed
0 $0
Q2 2020

Jul 13, 2020

BUY
$8.94 - $20.98 $237,955 - $558,424
26,617 Added 132.78%
46,663 $691,000
Q1 2020

Apr 29, 2020

SELL
$6.65 - $12.03 $138,187 - $249,983
-20,780 Reduced 50.9%
20,046 $219,000
Q4 2019

Feb 05, 2020

BUY
$5.43 - $9.22 $221,685 - $376,415
40,826 New
40,826 $358,000
Q3 2019

Oct 15, 2019

SELL
$7.47 - $10.76 $56,353 - $81,173
-7,544 Closed
0 $0
Q2 2019

Jul 26, 2019

BUY
$4.9 - $9.31 $20,158 - $38,301
4,114 Added 119.94%
7,544 $70,000
Q1 2019

Apr 18, 2019

BUY
$4.26 - $6.86 $8,034 - $12,937
1,886 Added 122.15%
3,430 $0
Q4 2018

Jan 16, 2019

SELL
$3.6 - $8.42 $60,818 - $142,247
-16,894 Reduced 91.63%
1,544 $6,000
Q3 2018

Oct 23, 2018

BUY
$6.33 - $8.08 $113,566 - $144,963
17,941 Added 3609.86%
18,438 $148,000
Q2 2018

Jul 30, 2018

BUY
$6.93 - $14.63 $3,444 - $7,271
497 New
497 $3,000

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $740M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.